Why the anti-COVID pill molnupiravir by Merck could be a game-changer for vaccine equity
Could COVID pills be a game-changer for vaccine equity?
Source: euronews.com
Stay updated with breaking news from Florian Kabinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Could COVID pills be a game-changer for vaccine equity?
Pharma company Merck has had significant results with their COVID-19 antiviral pill, the U.S. government has bought $1.7 million doses.